Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$143.85

38.37 (36.38%)

13:35
06/19/18
06/19
13:35
06/19/18
13:35

Sarepta price target raised to $205 from $87 at JPMorgan

JPMorgan analyst Anupam Rama said he is adding Sarepta's micro-dystrophin program to his model following the company's R&D day, reiterating his earlier call that the update "vastly exceeded" expectations. He estimates peak sales of $4B-$5B for the micro-dystrophin program, adding that the breadth of the pipeline highlighted at the R&D day leads him to believe Sarepta has the potential to enter the ranks of the "emerging large-caps" in the next 12-24 months. Rama raised his price target on Sarepta to $205 from $87 and keeps an Overweight rating on the shares.

  • 20

    Jun

SRPT Sarepta
$143.85

38.37 (36.38%)

06/15/18
BTIG
06/15/18
INITIATION
Target $120
BTIG
Buy
Sarepta initiated with a Buy at BTIG
BTIG analyst Timothy Chiang started Sarepta Therapeutics with a Buy rating and $120 price target. The company is the leader in the Duchenne muscular dystrophy space with its Exondys 51 estimated to generate sales of $300M in 2018, and its "extensive pipeline" of RNA-splicing product candidates, Chiang tells investors in a research note. While the stock is up 78% year-to-date, there is the potential for further upside as investors get additional visibility on Sarepta's gene therapy and phosphorodiamidate morpholino oligomer programs, the analyst contends.
06/15/18
JPMS
06/15/18
NO CHANGE
JPMS
Overweight
JPMorgan sees favorable setup for Sarepta into Tuesday's event
JPMorgan analyst Anupam Rama sees a favorable setup for shares of Sarepta Therapeutics(SRPT) into the company's R&D day on Tuesday, June 19. His scenario analysis points to a "very favorable" reward/risk profile of 20%-50% upside versus 10%-25% downside. If the gene therapy data meets or beats expectations, Sarepta will clearly be in the pole position in the micro-dystrophin space, Rama tells investors in a research note. The analyst adds that if the Sarepta micro-dystrophin data are viewed positively next week, a clear bar will have been set that Solid Biosciences (SLDB) will need to meet or beat. Rama continues to see risk to Solid shares ahead of next week's readout from Sarepta. He has an Overweight rating on Sarepta with an $87 price target and Underweight rating on Solid Biosciences with a $10 price target.
06/15/18
06/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. PetMed Express (PETS) initiated with a Neutral at CL King. 2. Cloudera (CLDR) initiated with a Reduce at Nomura Instinet. 3. Sarepta (SRPT) initiated with a Buy at BTIG. 4. Delphi Technologies (DLPH) initiated with a Perform at Oppenheimer. 5. Enerplus (ERF) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/18
JPMS
06/19/18
NO CHANGE
JPMS
Sarepta data beat 'grand slam scenario,' says JPMorgan
JPMorgan analyst Anupam Rama says the micro-dystrophin data reported this morning by Sarepta Therapeutics beat his "grand slam scenario." The stock in morning trading is up 59% to $166.99.

TODAY'S FREE FLY STORIES

LB

L Brands

$34.53

-0.75 (-2.13%)

16:33
11/19/18
11/19
16:33
11/19/18
16:33
Hot Stocks
Breaking Hot Stocks news story on L Brands »

L Brands reports Q3 SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LB

L Brands

$34.53

-0.75 (-2.13%)

16:32
11/19/18
11/19
16:32
11/19/18
16:32
Hot Stocks
L Brands to cut annual dividend to $1.20 from $2.40 »

After extensive review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

T

AT&T

$30.34

0.04 (0.13%)

16:32
11/19/18
11/19
16:32
11/19/18
16:32
Periodicals
CNN abandons WH suit after Acosta's press pass restored, WP says »

CNN has withdrawn its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 03

    Dec

YUM

Yum! Brands

$88.15

-0.77 (-0.87%)

, TGT

Target

$77.77

-1.9 (-2.38%)

16:31
11/19/18
11/19
16:31
11/19/18
16:31
Hot Stocks
Yum! Brands names Brian Cornell as non-executive Chairman of Board »

Yum! Brands (YUM)…

YUM

Yum! Brands

$88.15

-0.77 (-0.87%)

TGT

Target

$77.77

-1.9 (-2.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

LB

L Brands

$34.53

-0.75 (-2.13%)

16:31
11/19/18
11/19
16:31
11/19/18
16:31
Earnings
L Brands reports Q3 adjusted EPS 16c, consensus 15c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Earnings
Nuance sees FY19 EPS $1.02-$1.21, consensus $1.23 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Options
Preliminary option volume of 20.0M today »

Preliminary option volume…

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Hot Stocks
Breaking Hot Stocks news story on Nuance 

Nuance trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:28
11/19/18
11/19
16:28
11/19/18
16:28
Earnings
Nuance sees Q1 EPS 27c-29c, consensus 28c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LMB

Limbach Holding

$5.89

-0.17 (-2.81%)

16:27
11/19/18
11/19
16:27
11/19/18
16:27
Earnings
Limbach backs FY18 revenue view $530M-$550M, consensus $541.82M »

Backs FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PSTG

Pure Storage

$17.56

-1.56 (-8.16%)

16:27
11/19/18
11/19
16:27
11/19/18
16:27
Earnings
Pure Storage raises FY19 revenue view to $1.376B-$1.384B from $1.35B-$1.38B »

FY19 consensus $1.37B. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

LMB

Limbach Holding

$5.89

-0.17 (-2.81%)

16:26
11/19/18
11/19
16:26
11/19/18
16:26
Earnings
Limbach reports Q3 EPS (46c) vs (12c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

EBS

Emergent BioSolutions

$69.73

-1.36 (-1.91%)

16:26
11/19/18
11/19
16:26
11/19/18
16:26
Hot Stocks
Emergent BioSolutions and VLAS report 'positive' trial results for Zika vaccine »

Emergent BioSolutions and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 12

    Dec

NVLN

Novelion Therapeutics

$1.00

0.0192 (1.96%)

16:25
11/19/18
11/19
16:25
11/19/18
16:25
Hot Stocks
Breaking Hot Stocks news story on Novelion Therapeutics »

NB Public Equity reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$4.55

-0.14 (-2.99%)

16:24
11/19/18
11/19
16:24
11/19/18
16:24
Hot Stocks
Akoustis announces first 5.2 HGz WiFi pre-production order »

Akoustis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 11

    Dec

  • 12

    Dec

AAPL

Apple

$185.80

-7.62 (-3.94%)

, FB

Facebook

$131.62

-7.93 (-5.68%)

16:24
11/19/18
11/19
16:24
11/19/18
16:24
OnTheFly
Fly Intel: Wall Street's top stories for Monday »

Stocks opened in negative…

AAPL

Apple

$185.80

-7.62 (-3.94%)

FB

Facebook

$131.62

-7.93 (-5.68%)

NSANY

Nissan

$0.00

(0.00%)

REN

Resolute Energy

$34.72

4.21 (13.80%)

XEC

Cimarex Energy

$88.03

-0.6 (-0.68%)

NIO

NIO Inc.

$7.81

0.63 (8.77%)

CFX

Colfax

$23.72

-4.285 (-15.30%)

BX

Blackstone

$31.78

-0.7 (-2.16%)

MDLZ

Mondelez

$44.45

0.17 (0.38%)

CPB

Campbell Soup

$38.47

-0.17 (-0.44%)

JD

JD.com

$21.09

-1.95 (-8.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

DERM

Dermira

$9.73

0.04 (0.41%)

16:22
11/19/18
11/19
16:22
11/19/18
16:22
Upgrade
Dermira rating change  »

Dermira assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$48.42

-0.58 (-1.18%)

16:20
11/19/18
11/19
16:20
11/19/18
16:20
Hot Stocks
Thomson Reuters receives shareholder approval for return of capital transaction »

Thomson Reuters announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/19/18
11/19
16:20
11/19/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 19th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUS

Bellus Health

$0.00

(0.00%)

16:19
11/19/18
11/19
16:19
11/19/18
16:19
Conference/Events
Bellus Health to host conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORPN

Bio Blast Pharma

$1.19

-0.02 (-1.65%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
Bio Blast Pharma to acquire Enlivex Therapeutics »

Bioblast Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCRH

QCR Holdings

$36.85

-0.34 (-0.91%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
QCR Holdings says Douglas Hultquist will retire as CEO, Helling to succeed »

QCR Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAY

Accuray

$4.45

-0.27 (-5.72%)

, DHR

Danaher

$101.29

-1.95 (-1.89%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
Accuray names Shig Hamamatsu as CFO, effective immediately »

Accuray (ARAY) announced…

ARAY

Accuray

$4.45

-0.27 (-5.72%)

DHR

Danaher

$101.29

-1.95 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

  • 13

    Dec

JACK

Jack in the Box

$79.66

-0.97 (-1.20%)

16:17
11/19/18
11/19
16:17
11/19/18
16:17
Hot Stocks
Jack in the Box sees FY19 SSS flat to up 2%. »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
11/19/18
11/19
16:17
11/19/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.